MEN1 and pituitary tumor: Interestingly, 86% of all index cases with PHPT and pituitary tumors were MEN1 mutation-negative, whereas 69% of patients with PHPT associated with pituitary tumors and GEP-NETs were MEN1 mutation-positive (S1 Table).